11 July 2025 | 9:40AM CST China Healthcare: Jun 2025 China hospital equipment bidding: Growth on hold as ASP pressure unfolds, less expectation from stimulus in 2H We continue to track the procurement value of the main medical devices in China. Although the June bidding value data maintained a YoY growth rate of 49%, it still came in below our previous expectations due to a 3% MoM decline. We believe the decline was primarily driven by lower unit prices as a result of VBPs - continuing the trend observed in ...

Core Viewpoint - Medtronic plc has appointed Chad Spooner as the chief financial officer (CFO) of MiniMed, ahead of its planned separation into a standalone public company, effective July 14, 2025 [1][5]. Company Overview - Medtronic is a global leader in healthcare technology, headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [8]. - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions through various technologies and therapies [8]. Leadership Appointment - Chad Spooner brings over 25 years of financial leadership experience in healthcare, consumer, and industrial sectors, previously serving as CFO at BIC and holding senior finance roles at General Electric and other companies [2][4]. - His appointment is seen as crucial for driving transformation and growth as MiniMed prepares for independence [3][4]. MiniMed Separation - Medtronic announced that MiniMed will be the name of the new standalone company, honoring its 40-year legacy in diabetes care [3]. - The separation is expected to be completed within 18 months of the initial announcement, subject to customary conditions and legal requirements [5]. Mission and Vision - MiniMed's mission is to make diabetes management more predictable, enhancing the lives of individuals with diabetes through advanced technology and support [7].

ENGLEWOOD, Colo., July 2, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company received an update from Tricare that the temporary payment suspension will continue."As we previously announced, we were notified of a temporary suspension of payments from our largest insurance customer, Tricare," said Thomas Sandgaa ...

Company Leadership Change - Zynex, Inc. announced the appointment of Steven Dyson as Chief Executive Officer, effective August 18, 2025 [1] - Thomas Sandgaard, the founder and Chairman of the Board since 1996, will continue to be actively involved in the company [2] Executive Experience - Steven Dyson brings over 25 years of experience in the medical technology sector, with a strong background in private equity and leadership roles in various healthcare companies [3] - His previous experience includes significant roles in companies such as KCI, Rodenstock, Healthium Medtech, Unilabs, and Neuraxpharm [3] Strategic Focus - The company aims to refocus its business strategy towards a more optimized payer mix and to return to a strong growth trajectory under Dyson's leadership [5] - Dyson expressed enthusiasm about leading Zynex and emphasized the strong foundation built by Sandgaard [5] Company Overview - Zynex develops, manufactures, markets, and sells medical devices for pain management and rehabilitation, as well as non-invasive monitoring systems for hospitals [10]

Core Insights - Medtronic plc has appointed Dr. Joon Lee, CEO of Emory Healthcare, as an independent director on its Board, effective June 18, 2025 [1] - Dr. Lee will contribute to the Science and Technology Committee and Compensation and Talent Committee [1] Company Overview - Medtronic is a global leader in healthcare technology, headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [6] - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions with its technologies [6] Dr. Joon Lee's Background - Dr. Lee has over 25 years of experience at the University of Pittsburgh Medical Center (UPMC), where he held significant roles including Executive Vice President and President of Physician Services [3] - He has a strong background in cardiology, having served as Chief of the Division of Cardiology and founding executive director of the UPMC Heart and Vascular Institute [4] - Dr. Lee's educational credentials include a BA from Dartmouth College and an MD from Duke University, along with extensive training in cardiology at Massachusetts General Hospital [5] Financial and Operational Insights - Emory Healthcare, under Dr. Lee's leadership, generates $7.7 billion in annual revenue and operates 12 hospitals with over 29,000 employees [2] - Dr. Lee also served as Chief Medical Officer of UPMC Insurance Services, which is a $13 billion health insurance division [4] Strategic Vision - Dr. Lee is recognized for his commitment to leveraging data and technology to enhance patient and provider experiences, aligning with Medtronic's mission [2]

12 Jun 2025 22:05:46 ET │ 12 pages Flash | China Healthcare Strong tendering growth continued in May 2025 CITI'S TAKE The medical equipment sector is on track for recovery since last Nov – the tendering continued to grow strongly in May 2025 with yoy growth of 78%, according to Joinchain. Data in Jun will be released around mid Jul. Among leading medical equipment companies, Mindray maintained robust growth of 56% yoy; United Imaging grew by 11% yoy after a surge of 208% yoy in Apr. The strong growth moment ...

Summary of OSI Systems Conference Call Company Overview - OSI Systems operates in three divisions: Security, Health Care, and Optoelectronics [3][4] - The Security division, RapidScan Systems, accounts for over two-thirds of revenues and is a leader in security detection [4][5] Key Points and Arguments Security Division - The Security division is primarily known for aviation products but is experiencing rapid growth in cargo and border solutions, particularly in the U.S. and internationally [4][5][10] - The U.S. government has significantly increased funding for non-intrusive inspection (NII) technology, with a proposed budget of $1.1 billion, quadrupling previous expectations of $300 million [12][14] - International growth remains strong, with notable opportunities in the Middle East, Latin America, Asia, and Europe [10][12] Revenue and Growth - Recent contracts in Mexico have matured, leading to a 50% decline in revenues from that region, but overall security revenues increased by 10% [15][16] - The service revenue from the installed base in Mexico is expected to increase as products roll off warranty, leading to higher margins [16][21] - The life cycle of security products is approximately 7-10 years, with aftermarket service revenues potentially doubling the initial product sale [20][21] Optoelectronics Division - The Opto business has shown resilience during a destocking period, with a 15% growth in the last quarter [30][31] - Companies are increasingly looking to shift manufacturing away from China, presenting opportunities for OSI Systems due to its global manufacturing footprint [32] Health Care Division - A new patient monitoring platform is set to launch in summer 2024, which is expected to drive significant growth [34][36] - The health care division has the highest contribution margins, and improvements in top-line revenue could lead to higher operating margins [36] Cash Flow and Financial Outlook - Free cash flow conversion is expected to be strong, with significant cash generation anticipated in fiscal 2026 [41][42] - The company has a disciplined approach to capital allocation, focusing on M&A, stock buybacks, and debt reduction [52][53] Market Position and Competition - OSI Systems is the largest security detection company and continues to gain market share, particularly in ports and borders [66][68] - The company is exploring acquisitions primarily in the security and optoelectronics sectors, with a focus on bolt-on opportunities [62][63] Leadership Transition - A new CEO has been appointed from within the company, ensuring continuity in strategy and operations [69][70] Margins and Future Expectations - Margins in the aviation sector are expected to be comparable to those in the cargo and border sectors, with no anticipated negative impact on overall operating margins [72] Additional Important Points - The company is actively managing costs, with SG&A as a percentage of sales decreasing as revenues grow [49][50] - Tariffs are not expected to have a material impact on the business, with the health care division being the most exposed [56][57] - The company has adequate manufacturing capacity to meet growing demand without significant new investments [60][61]

10 June 2025 | 6:06PM CST China Healthcare: May 2025 China hospital equipment bidding: YoY growth continued, while VBP hits ultrasound price We continue to track the procurement value of main medical devices in China. As we expected, the May data showed continued strong YoY growth (+91%), but a MoM decline (-13%). Taking into account that May 2024 was a low base caused by delays in trade-in program, comparing the May 2025 data to May 2023 still reveals a 33% increase. In our view, this indicates that hospit ...

efficient and expedited prior authorization processes and exchange of health information. Payers and providers must comply with the new Prior Authorization API requirements by January 2027. In addition, beginning in 2026, payers must provide a specific reason for a denied prior authorization request to both providers and patients. Breaking barriers: 5 collaborative strategies to ensure effective healthcare operations Breaking barriers: 5 collaborative strategies to ensure effective healthcare operations 1 I ...

Core Viewpoint - Medtronic plc will participate in Bernstein's 41st Strategic Decisions Conference on May 29, 2025, where CEO Geoff Martha will present and answer questions alongside CFO Thierry Piéton [1][2]. Company Overview - Medtronic is a leading global healthcare technology company headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [4]. - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions through various technologies and therapies, including cardiac devices, surgical robotics, and patient monitoring systems [4]. - Medtronic aims to deliver innovative technologies that transform lives, impacting two people every second [4]. Event Details - The presentation by CEO Geoff Martha will begin at 11:00 a.m. EDT on May 29, 2025, followed by a Q&A session with CFO Thierry Piéton [2]. - A live webcast of the event will be available on Medtronic's investor relations website, with an archive accessible later the same day [3].